Recombinant human thyrotropin before 131I therapy improves goiter reduction

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2006年 / 2卷 / 10期
关键词：
D O I：
10.1038/ncpendmet0259
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：534 / 534
相关论文
共 50 条
  • [1] Recombinant human thyrotropin stimulated 131I treatment for multinodular goiter
    Tang, Limin
    Ma, Tiekun
    Wu, Fengyu
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016, 55 (06): : 228 - 235
  • [2] Recombinant Human Thyrotropin Stimulation Before 131I Therapy in Toxic Multinodular Goiter with Low Radioactive Iodine Uptake
    Azorin-Belda, M.
    Martinez-Caballero, A.
    Figueroa-Ardila, G. C.
    Gomez-Jaramillo, C. A.
    Verdu-Rico, J.
    Dolado-Ardid, J. I.
    Anton-Leal, M.
    Martinez-Ramirez, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S762 - S762
  • [3] Radioiodine 131I Treatment for Large Nodular Goiter: Recombinant Human Thyrotropin Allows the Reduction of Radioiodine 131I Activity to Be Administered in Patients with Low Uptake
    Ceccarelli, Claudia
    Antonangeli, Lucia
    Brozzi, Federica
    Bianchi, Francesca
    Tonacchera, Massimo
    Santini, Pierina
    Mazzeo, Salvatore
    Bencivelli, Walter
    Pinchera, Aldo
    Vitti, Paolo
    THYROID, 2011, 21 (07) : 759 - 764
  • [4] Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter:: An evaluation by a randomized double-blinded trial
    Nielsen, VE
    Bonnema, SJ
    Boel-Jorgensen, H
    Veje, A
    Hegedüs, L
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01): : 79 - 83
  • [5] Recombinant human thyrotropin before 131I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials
    Lee, Yen-Ying
    Tam, Ka-Wai
    Lin, You-Meei
    Leu, Wuan-Jin
    Chang, Jui-Chia
    Hsiao, Chi-Lien
    Hsu, Meng-Ting
    Hsieh, An-Tsz
    CLINICAL ENDOCRINOLOGY, 2015, 83 (05) : 702 - 710
  • [6] Recombinant human thyrotropin stimulation prior to 131I therapy in toxic multinodular goitre with low radioactive iodine uptake
    Azorin Belda, M. J.
    Martinez Caballero, A.
    Figueroa Ardila, G. C.
    Martinez Ramirez, M.
    Gomez Jaramillo, C. A.
    Dolado Ardit, J. I.
    Verdu Rico, J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (01): : 7 - 12
  • [7] Recombinant human thyrotropin is helpful in the follow-up and 131I therapy of patients with thyroid cancer:: A report of the results and benefits using recombinant human thyrotropin in clinical routine
    Kohlfuerst, S
    Igerc, I
    Lind, P
    THYROID, 2005, 15 (04) : 371 - 376
  • [8] The effects of the radioiodine therapy on toxic nodular goiter with bordering thyroid 131I uptake (RAIU), stimulated and non stimulated with single, low dose of recombinant human thyrotropin (rhTSH).
    Parfienczyk, A. A.
    Rogowski, F.
    Abdelrazek, S. S.
    Kiersnowska-Rogowska, B.
    Szumowski, P.
    Kociura-Sawicka, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S158 - S158
  • [9] Evaluation of the cytogenetic effects of 131I preceded by recombinant human thyrotropin (rhTSH) in peripheral lymphocytes of Wistar rats
    da Silva, Marcia Augusta
    Calil Cury Guimaraes, Maria Ines
    Yoriyaz, Helio
    Carvalho Pinto Ribela, Maria Teresa
    Buchpiguel, Carlos Alberto
    Bartolini, Paolo
    Okazaki, Kayo
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2008, 47 (04) : 453 - 461
  • [10] Evaluation of the cytogenetic effects of 131I preceded by recombinant human thyrotropin (rhTSH) in peripheral lymphocytes of Wistar rats
    Márcia Augusta da Silva
    Maria Inês Calil Cury Guimarães
    Hélio Yoriyaz
    Maria Teresa Carvalho Pinto Ribela
    Carlos Alberto Buchpiguel
    Paolo Bartolini
    Kayo Okazaki
    Radiation and Environmental Biophysics, 2008, 47 : 453 - 461
12345